What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
Enregistré dans:
Auteurs principaux: | Ivar Sonbo Kristiansen, Stein Kaasa, Christoffer Bugge, Erik Magnus Sæther, Hans Olav Melberg |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMJ Publishing Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e9a4cecc7ab54a898d9af6e9d5a4fb08 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Equitable access to cancer patient pathways in Norway – a national registry-based study
par: Frank Olsen, et autres
Publié: (2021) -
Norwegian physicians' knowledge of and opinions about evidence-based medicine: cross-sectional study.
par: Lidziya Vanahel Ulvenes, et autres
Publié: (2009) -
Pharmaceutical Aspects of Nanocarriers for Smart Anticancer Therapy
par: Seung Rim Hwang, et autres
Publié: (2021) -
Impacts of wild fishes attracted to open-cage salmonid farms in Norway
par: I Uglem, et autres
Publié: (2014) -
I Know What you Did Last Summer
par: Bill Schindler
Publié: (2013)